These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32098570)

  • 1. Access to Controlled Medicines in Low-Income Countries: Listening to Stakeholders in the Field.
    Vitry A; Forte G; White J
    Int J Health Serv; 2021 Jul; 51(3):404-411. PubMed ID: 32098570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of government agencies and other actors in influencing access to medicines in three East African countries.
    Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
    Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?
    Srivastava D; McGuire A
    BMC Public Health; 2014 Jul; 14():767. PubMed ID: 25073407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking health sector procurement as developmental linkages in East Africa.
    Mackintosh M; Tibandebage P; Karimi Njeru M; Kariuki Kungu J; Israel C; Mujinja PGM
    Soc Sci Med; 2018 Mar; 200():182-189. PubMed ID: 29421465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries.
    Bigdeli M; Javadi D; Hoebert J; Laing R; Ranson K;
    Health Res Policy Syst; 2013 Oct; 11():37. PubMed ID: 24124696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to controlled medicines for anesthesia and surgical care in low-income countries: a narrative review of international drug control systems and policies.
    Nickerson JW; Pettus K; Wheeler KE; Hallam C; Bewley-Taylor DR; Attaran A; Gelb AW
    Can J Anaesth; 2017 Mar; 64(3):296-307. PubMed ID: 28050803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to cancer medication in public hospitals in a middle-income country: The view of stakeholder.
    Moye-Holz D; Dreser A; van Dijk JP; Reijneveld SA; Hogerzeil HV
    Res Social Adm Pharm; 2020 Sep; 16(9):1255-1263. PubMed ID: 31796333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Access to essential drugs in developing countries].
    Rojo P
    Gac Sanit; 2001; 15(6):540-5. PubMed ID: 11858791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
    Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
    PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
    Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
    BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
    Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
    Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of Uganda.
    Osinde G; Niyonzima N; Mulema V; Kyambadde D; Mulumba Y; Obayo S; Anecho E; Watera S; Constance M; Kadhumbula S; Orem J
    Future Oncol; 2021 Jul; 17(21):2735-2745. PubMed ID: 33855863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to Accessing Internationally Controlled Essential Medicines in Uganda: A Qualitative Study.
    Ooms GI; Klatser P; van den Ham HA; Reed T
    J Pain Symptom Manage; 2019 Nov; 58(5):835-843.e1. PubMed ID: 31302261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.
    Vialle-Valentin CE; Serumaga B; Wagner AK; Ross-Degnan D
    Health Policy Plan; 2015 Oct; 30(8):1044-52. PubMed ID: 25255920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening access to cancer medicines for children in East Africa: policy options to enhance medicine procurement, forecasting, and regulations.
    Petricca K; Carson L; Kambugu J; Denburg A
    Glob Health Res Policy; 2024 Jul; 9(1):24. PubMed ID: 38951949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers.
    Tang B; Bodkyn C; Gupta S; Denburg A
    JCO Glob Oncol; 2020 Feb; 6():67-79. PubMed ID: 32031441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries.
    Barr R; Robertson J
    Pediatr Blood Cancer; 2016 Feb; 63(2):287-91. PubMed ID: 26375626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scheduling medicines as controlled substances: addressing normative and democratic gaps through human rights-based analysis.
    Lohman D; Barrett D
    BMC Int Health Hum Rights; 2020 Apr; 20(1):10. PubMed ID: 32316971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.